PCN51 OUTCOMES MANAGEMENT IN A REAL WORLD EVIDENCE CONTEXT. THE CASE OF ABIRATERONE AND ENZALUTAMIDE IN THE TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

Saved in:
Bibliographic Details
Published in:Value in health 2019-11, Vol.22, p.S445-S445
Main Authors: Cardoso, P., Santos, C., Costa, F., Gonçalves, F.R.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1098-3015
1524-4733
DOI:10.1016/j.jval.2019.09.248